NewAge Stock Forecast, Price & News

NewAge (NASDAQ:NBEV) Frequently Asked Questions

Is NewAge a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NewAge in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NewAge stock.
View analyst ratings for NewAge or view top-rated stocks.

How has NewAge's stock been impacted by Coronavirus?

NewAge's stock was trading at $1.72 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NBEV shares have decreased by 27.9% and is now trading at $1.24.
View which stocks have been most impacted by COVID-19.

When is NewAge's next earnings date?

NewAge is scheduled to release its next quarterly earnings announcement on Tuesday, March 15th 2022.
View our earnings forecast for NewAge.

How were NewAge's earnings last quarter?

NewAge, Inc. (NASDAQ:NBEV) posted its earnings results on Tuesday, November, 9th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by $0.08. NewAge had a negative net margin of 1.62% and a negative trailing twelve-month return on equity of 22.01%. During the same period in the prior year, the firm posted ($0.14) earnings per share.
View NewAge's earnings history.

What price target have analysts set for NBEV?

2 analysts have issued twelve-month price objectives for NewAge's shares. Their forecasts range from $6.00 to $6.00. On average, they anticipate NewAge's share price to reach $6.00 in the next twelve months. This suggests a possible upside of 383.9% from the stock's current price.
View analysts' price targets for NewAge or view top-rated stocks among Wall Street analysts.

Who are NewAge's key executives?

NewAge's management team includes the following people:

• Brent David Willis, Chief Executive Officer & Director
• Mark Wilson, Group President
• Phil Lewis, Senior Vice President-Operations
• Kevin Manion, Chief Financial Officer
• Blake Heringer, Chief Information Officer

Who are some of NewAge's key competitors?

Some companies that are related to NewAge include Anheuser-Busch InBev SA/NV (BUD), Heineken (HEINY), Carlsberg A/S (CABGY), Kirin (KNBWY), Tsingtao Brewery (TSGTY), Molson Coors Beverage (TAP), Boston Beer (SAM), San Miguel (SMGBY), Compañía Cervecerías Unidas (CCU), Big Rock Brewery (BRBMF), China New Borun (BORNY) and Mendocino Brewing (MENB).
View all of NBEV's competitors.

What other stocks do shareholders of NewAge own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NewAge investors own include (CGC), Aurora Cannabis (ACB), Tilray (TLRY), Cronos Group (CRON), Advanced Micro Devices (AMD), Micron Technology (MU), NIO (NIO), BHP Group (BHP), (APHA) and General Electric (GE).

What is NewAge's stock symbol?

NewAge trades on the NASDAQ under the ticker symbol "NBEV."

Who are NewAge's major shareholders?

NewAge's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Geode Capital Management LLC (1.58%), Renaissance Technologies LLC (1.08%), Morgan Stanley (0.63%), Trek Financial LLC (0.49%), Millennium Management LLC (0.46%) and Marshall Wace LLP (0.42%). Company insiders that own NewAge stock include Ed Brennan and Timothy J Haas.
View institutional ownership trends for NewAge.

Which institutional investors are selling NewAge stock?

NBEV stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Dimensional Fund Advisors LP, Davy Global Fund Management Ltd, Renaissance Technologies LLC, Geode Capital Management LLC, California State Teachers Retirement System, Jane Street Group LLC, and New York State Common Retirement Fund.
View insider buying and selling activity for NewAge or view top insider-selling stocks.

Which institutional investors are buying NewAge stock?

NBEV stock was purchased by a variety of institutional investors in the last quarter, including Trek Financial LLC, Marshall Wace LLP, Morgan Stanley, Vident Investment Advisory LLC, StoneX Group Inc., Perritt Capital Management Inc., SG Americas Securities LLC, and Symons Capital Management Inc.. Company insiders that have bought NewAge stock in the last two years include Ed Brennan, and Timothy J Haas.
View insider buying and selling activity for NewAge or or view top insider-buying stocks.

How do I buy shares of NewAge?

Shares of NBEV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NewAge's stock price today?

One share of NBEV stock can currently be purchased for approximately $1.24.

How much money does NewAge make?

NewAge has a market capitalization of $169.62 million and generates $279.47 million in revenue each year. The company earns $-39.34 million in net income (profit) each year or ($0.32) on an earnings per share basis.

How many employees does NewAge have?

NewAge employs 1,127 workers across the globe.

What is NewAge's official website?

The official website for NewAge is newagebev.us.

Where are NewAge's headquarters?

NewAge is headquartered at 2420 17TH STREET SUITE 220, DENVER CO, 80202.

How can I contact NewAge?

NewAge's mailing address is 2420 17TH STREET SUITE 220, DENVER CO, 80202. The company can be reached via phone at (303) 566-3030 or via email at [email protected].